Investor Relations

NYSE: TDOC +7.16 +4.29%
Volume: 5,770,936
20 minute delay May 29, 2020

At Teladoc Health, we are transforming how people access healthcare around the world

Teladoc Health is the global virtual care leader, helping millions of people resolve their healthcare needs with confidence.

We have unified the combined capabilities and global market presence of our award-winning consumer experience brands to create the only comprehensive virtual care solution capable of serving organizations and people everywhere.

Investor Events

Investor News

May 14, 2020
Teladoc Health Prices Upsized Offering of $850 Million of Convertible Senior Notes due 2027
PURCHASE, NY, May 14, 2020 (GLOBE NEWSWIRE) - Teladoc Health, Inc. (NYSE:TDOC) (“Teladoc Health”) today announced the pricing of its offering of $850 million aggregate principal amount of Convertible Senior Notes due 2027 (the “Notes”) in a private offering to qualified institutional buyers pursuant to an exemption from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The size of the offering was increased by $50 million from the previously announced offering size of $800 million. In connection with the offering of the Notes, Teladoc Health granted the initial purchasers of the Notes an option to purchase, for settlement within a period of 13 days from, and including, the closing date for the offering of the Notes, up to an additional $150 million aggregate principal amount of Notes on the same terms and conditions. The sale of the Notes is scheduled to close on May 19, 2020, subject to satisfaction of customary closing conditions. ...
Read More
May 14, 2020
Teladoc Health Announces Proposed Offering of $800 Million of Convertible Senior Notes due 2027
PURCHASE, NY, May 14, 2020 (GLOBE NEWSWIRE) - Teladoc Health, Inc. (NYSE: TDOC) (“Teladoc Health”) today announced its intention to offer, subject to market conditions and other factors, $800 million aggregate principal amount of Convertible Senior Notes due 2027 (the “Notes”) in a private offering to qualified institutional buyers pursuant to an exemption from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). In connection with the offering of the Notes, Teladoc Health expects to grant the initial purchasers of the Notes an option to purchase, for settlement within a period of 13 days from, and including, the closing date for the offering of the Notes, up to an additional $120 million aggregate principal amount of Notes on the same terms and conditions.
Teladoc Health intends to use a portion of the net proceeds of the offering to enter into privately negotiated agreements with certain holders of its 3.00% Convertible Senior Notes...
Read More

Get in touch today

Contact Teladoc Health Investor Relations

Patrick Feeley

Vice President, Investor Relations